Christina Jackson

Christina Jackson is an Associate Editor at GEN. She joined GEN in 2019 after working five years in animal care and deciding to pursue her passion for English literature and writing. Christina holds a BA in English from Lehman College. In her role at GEN, she helps produce content related to translational medicine, protein folding, and other biotech advancements. When not working, Christina enjoys playing video games, watching anime, and spending time with her family and friends.

Biography:  https://www.genengnews.com/gen-staff/

99%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

  • The editorial team at GEN is composed of experienced professionals with backgrounds in science publishing, journalism, and editing.

Conflicts of Interest

100%

Examples:

  • There are no conflicts of interest found in the articles provided.

Contradictions

100%

Examples:

  • There are no major contradictions found in the articles provided.

Deceptions

100%

Examples:

  • There are no deceptive practices found in the articles provided.

Recent Articles

New Autoantibody Signature Identified in 10% of Multiple Sclerosis Patients Years Before Symptoms Appear: Implications for Earlier Detection and Treatment

New Autoantibody Signature Identified in 10% of Multiple Sclerosis Patients Years Before Symptoms Appear: Implications for Earlier Detection and Treatment

Broke On: Monday, 01 April 2024 Researchers from UC San Francisco and the Department of Defense Serum Repository identify unique autoantibody signature in 10% of multiple sclerosis (MS) patients years before symptoms appear, paving way for earlier diagnosis and treatment. Discovery could lead to a simple blood test for early detection, allowing for timely intervention with more effective therapies.

Breakthrough in Protein Folding Understanding Opens New Therapeutic Avenues

Broke On: Monday, 04 December 2023 Researchers at the University of Massachusetts Amherst have deciphered a carbohydrate-based code that is critical for protein folding. The study focused on a family of proteins known as serpins, which are implicated in various diseases. The enzyme UGGT tags misfolded proteins with sugars in specific positions, allowing chaperones to determine where the folding process went wrong and how to fix it.